MyAverix Finance
US · Healthcare
Evaxion Biotech AS (EVAX)
Biotechnology
Evaxion Biotech AS (EVAX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for EVAX
Evaxion Biotech AS (EVAX) — FAQ
What is EVAX's P/E ratio?
The price-to-earnings (P/E) ratio for Evaxion Biotech AS (EVAX) is 18.00 (data as of 2026-03-24).
Does Evaxion Biotech AS pay a dividend?
Dividend yield is not available in the current snapshot for Evaxion Biotech AS (EVAX). Check the MyAverix Finance app for the latest dividend data.
What sector is Evaxion Biotech AS in?
Evaxion Biotech AS (EVAX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is EVAX listed on?
EVAX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.